CPT2
Carnitine O-palmitoyltransferase 2, mitochondrial
As of the edition of 20 October 2026, CPT2 (carnitine O-palmitoyltransferase 2, mitochondrial, UniProt P23786) has 1 drug tested at it and 0 companies on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P23786
- How well studied
- Chemical tools exist; no approved drug acts on it
- Where it sits in the cell
- At a membrane
- Disease areas
- Heart and blood vessels; Inherited and neonatal
- Registered trials of its drugs
- 8
Drugs at this target
| Status | Count |
|---|---|
| Withdrawn from market | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Perhexiline | Withdrawn from market | Phase 3 | none listed |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Total on the list | 0 |